BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29305709)

  • 21. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.
    Solomayer EF; Feuerer M; Bai L; Umansky V; Beckhove P; Meyberg GC; Bastert G; Schirrmacher V; Diel IJ
    Clin Cancer Res; 2003 Jan; 9(1):174-80. PubMed ID: 12538466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study.
    Zimmer P; Jäger E; Bloch W; Zopf EM; Baumann FT
    BMC Cancer; 2013 Jun; 13():272. PubMed ID: 23731674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte recovery after breast cancer treatment and mindfulness-based stress reduction (MBSR) therapy.
    Lengacher CA; Kip KE; Post-White J; Fitzgerald S; Newton C; Barta M; Jacobsen PB; Shelton MM; Moscoso M; Johnson-Mallard V; Harris E; Loftus L; Cox C; Le N; Goodman M; Djeu J; Widen RH; Bercu BB; Klein TW
    Biol Res Nurs; 2013 Jan; 15(1):37-47. PubMed ID: 22084404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strength, workload, anaerobic intensity and the immune response to resistance exercise in women.
    Miles MP; Kraemer WJ; Nindl BC; Grove DS; Leach SK; Dohi K; Marx JO; Volek JS; Mastro AM
    Acta Physiol Scand; 2003 Jun; 178(2):155-63. PubMed ID: 12780390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
    Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
    J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte and T-cell responses to exercise training in elderly subjects.
    Shimizu K; Suzuki N; Imai T; Aizawa K; Nanba H; Hanaoka Y; Kuno S; Mesaki N; Kono I; Akama T
    J Strength Cond Res; 2011 Sep; 25(9):2565-72. PubMed ID: 21685807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical training during intrahepatic chemotherapy.
    Kelm J; Ahlhelm F; Weissenbach P; Schliesing P; Regitz T; Deubel G; Engel C
    Arch Phys Med Rehabil; 2003 May; 84(5):687-90. PubMed ID: 12736882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response, depression and fatigue in relation to support intervention in mammary cancer patients.
    Lindemalm C; Mozaffari F; Choudhury A; Granstam-Björneklett H; Lekander M; Nilsson B; Ojutkangas ML; Osterborg A; Bergkvist L; Mellstedt H
    Support Care Cancer; 2008 Jan; 16(1):57-65. PubMed ID: 17562086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of resistance training on selected indexes of immune function in elderly women.
    Flynn MG; Fahlman M; Braun WA; Lambert CP; Bouillon LE; Brolinson PG; Armstrong CW
    J Appl Physiol (1985); 1999 Jun; 86(6):1905-13. PubMed ID: 10368355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial.
    Hornsby WE; Douglas PS; West MJ; Kenjale AA; Lane AR; Schwitzer ER; Ray KA; Herndon JE; Coan A; Gutierrez A; Hornsby KP; Hamilton E; Wilke LG; Kimmick GG; Peppercorn JM; Jones LW
    Acta Oncol; 2014 Jan; 53(1):65-74. PubMed ID: 23957716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
    Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
    Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of physical activity on the cellular immune system: mechanisms of action.
    Pedersen BK
    Int J Sports Med; 1991 Jun; 12 Suppl 1():S23-9. PubMed ID: 1894394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of mild acute stress on immune cell distribution and natural killer cell activity in breast cancer patients.
    van der Pompe G; Antoni MH; Visser A; Heijnen CJ
    Biol Psychol; 1998 May; 48(1):21-35. PubMed ID: 9676357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a supervised exercise intervention on recovery from treatment regimens in breast cancer survivors.
    Hsieh CC; Sprod LK; Hydock DS; Carter SD; Hayward R; Schneider CM
    Oncol Nurs Forum; 2008 Nov; 35(6):909-15. PubMed ID: 18980921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.
    Mackay IR; Goodyear MD; Riglar C; Penschow J; Whittingham S; Russell IS; Kitchen PR; Collins JP
    Cancer; 1984 Jun; 53(12):2619-27. PubMed ID: 6609758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial.
    Schmidt ME; Wiskemann J; Armbrust P; Schneeweiss A; Ulrich CM; Steindorf K
    Int J Cancer; 2015 Jul; 137(2):471-80. PubMed ID: 25484317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study).
    Schmidt ME; Wiskemann J; Krakowski-Roosen H; Knicker AJ; Habermann N; Schneeweiss A; Ulrich CM; Steindorf K
    Contemp Clin Trials; 2013 Jan; 34(1):117-25. PubMed ID: 23103936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
    Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy.
    Mozaffari F; Lindemalm C; Choudhury A; Granstam-Björneklett H; Helander I; Lekander M; Mikaelsson E; Nilsson B; Ojutkangas ML; Osterborg A; Bergkvist L; Mellstedt H
    Br J Cancer; 2007 Jul; 97(1):105-11. PubMed ID: 17551492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.